Overview
- 51 inspections across 50 sites are on record.
- 191 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
51
Sites
50
Observations
191
Career since
Oct 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Unither Manufacturing LLC. | 15 May 2026 | Human Drugs | On file |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 8 Apr 2026 | Human Drugs | On file |
| Fougera Pharmaceuticals, LLC. | 26 Mar 2026 | Human Drugs | On file |
| Sharp Sterile Manufacturing, LLC | 5 Mar 2026 | Human Drugs | On file |
| PETNET Solutions, Inc. | 9 Jan 2026 | Human Drugs | On file |
Sites inspected
Unither Manufacturing LLC.Rochester, United States1 insp.
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
Fougera Pharmaceuticals, LLC.Hicksville, United States1 insp.
Sharp Sterile Manufacturing, LLCLee, United States1 insp.
PETNET Solutions, Inc.Albany, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sony Mathews5 shared
Young K Chou4 shared
Nelson N Ayangho4 shared
Tanya R Syffrard4 shared
Divek R Jumani3 shared
Ruben C Quintana3 shared
Junho Pak3 shared
Erik W Koester2 shared
Catherine O Lamptey2 shared
Suchan Kim2 shared
Full investigator report
Get the verbatim findings behind Syeda N Mahazabin's 191 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site